HEARTLAND ADVISORS INC - AVANOS MED INC ownership

AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 264 filers reported holding AVANOS MED INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
HEARTLAND ADVISORS INC ownership history of AVANOS MED INC
ValueSharesWeighting
Q1 2024$3,172,679
-66.4%
159,351
-59.3%
0.17%
-66.3%
Q4 2023$9,443,546
-26.1%
391,091
-31.8%
0.49%
-31.3%
Q3 2023$12,775,623
-12.9%
573,095
-0.2%
0.72%
-14.5%
Q2 2023$14,674,302
-0.4%
574,112
+15.9%
0.84%
-7.7%
Q1 2023$14,730,401
+25.6%
495,306
+14.3%
0.91%
+22.5%
Q4 2022$11,727,155
+16.6%
433,376
-6.1%
0.74%
-1.2%
Q3 2022$10,056,000
-6.9%
461,714
+16.8%
0.75%
+0.1%
Q2 2022$10,803,000
-7.6%
395,141
+13.3%
0.75%
+3.6%
Q1 2022$11,687,000
-3.3%
348,854
+0.1%
0.72%
+2.4%
Q4 2021$12,080,000
+26.0%
348,437
+13.3%
0.71%
+22.5%
Q3 2021$9,591,000
+9.5%
307,416
+27.7%
0.58%
+14.0%
Q2 2021$8,755,000
-11.3%
240,724
+6.6%
0.51%
-18.8%
Q1 2021$9,873,000
-7.1%
225,724
-2.5%
0.62%
-17.8%
Q4 2020$10,623,000
+24.2%
231,533
-10.1%
0.76%
+2.0%
Q3 2020$8,554,000
+13.0%
257,4840.0%0.74%
+10.5%
Q2 2020$7,567,000
+18.8%
257,484
+8.9%
0.67%
-1.0%
Q1 2020$6,367,000
+263.8%
236,444
+355.2%
0.68%
+427.1%
Q4 2019$1,750,000
-42.1%
51,940
-35.6%
0.13%
-44.2%
Q3 2019$3,023,000
-57.2%
80,702
-50.2%
0.23%
-55.5%
Q2 2019$7,061,000
+52.2%
161,922
+48.9%
0.52%
+51.3%
Q1 2019$4,640,000108,7110.34%
Other shareholders
AVANOS MED INC shareholders Q4 2023
NameSharesValueWeighting ↓
Paradice Investment Management LLC 2,441,913$88,812,0004.12%
RGM Capital, LLC 2,157,612$78,472,0003.63%
Millrace Asset Group, Inc. 32,253$1,173,0000.61%
HEARTLAND ADVISORS INC 240,724$8,755,0000.51%
Champlain Investment Partners, LLC 2,607,033$94,818,0000.45%
Campbell & CO Investment Adviser LLC 27,200$989,0000.41%
S.A. Mason LLC 5,565$202,0000.14%
XTX Topco Ltd 8,240$300,0000.10%
AIGEN INVESTMENT MANAGEMENT, LP 15,186$552,0000.10%
OCCUDO QUANTITATIVE STRATEGIES LP 16,875$614,0000.09%
View complete list of AVANOS MED INC shareholders